FDA 483 - Pyramid Laboratories, Inc. - September 29, 2021

Pyramid Laboratories, Inc. in Costa Mesa, CA, received a Form 483 with five observations during an FDA inspection. The findings highlight significant deficiencies in quality control, including inadequate sampling plans, environmental monitoring, laboratory instrument calibration, and data integrity controls for computer systems. These issues indicate a moderate level of non-compliance with good manufacturing practices.